KRAS Vaccine: First-In-Human Immune Response Against Pancreatic Cancer
Scientists have reported that an experimental vaccine targeting one of the most common genetic drivers of pancreatic cancer, called mutant KRAS, is safe and generated a durable immune responses aimed at preventing the cancer.
